164 related articles for article (PubMed ID: 3046293)
1. Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition.
Drexler H; Hiroi M; Riede U; Banhardt U; Meinertz T; Just H
Am J Cardiol; 1988 Sep; 62(8):82E-85E. PubMed ID: 3046293
[TBL] [Abstract][Full Text] [Related]
2. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
[TBL] [Abstract][Full Text] [Related]
3. Adaptive changes in the periphery and their therapeutic consequences.
Drexler H; Münzel T; Riede U; Just H
Am J Cardiol; 1991 May; 67(12):29C-34C; discussion 34C-35C. PubMed ID: 2021116
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure.
Drexler H
Am J Cardiol; 1992 Oct; 70(10):50C-54C. PubMed ID: 1414895
[TBL] [Abstract][Full Text] [Related]
5. Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure.
Wilson JR; Ferraro N
J Am Coll Cardiol; 1985 Sep; 6(3):556-63. PubMed ID: 2993396
[TBL] [Abstract][Full Text] [Related]
6. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
Münzel T; Kurz S; Drexler H
Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
LeJemtel TH; Scortichini D; Katz S
Am J Cardiol; 1988 Sep; 62(8):36E-39E. PubMed ID: 3046291
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M
Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278
[TBL] [Abstract][Full Text] [Related]
9. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG
Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289
[TBL] [Abstract][Full Text] [Related]
10. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment.
Massie BM
Am J Med; 1988 Mar; 84(3A):75-82. PubMed ID: 3064602
[No Abstract] [Full Text] [Related]
11. Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure.
Poole-Wilson PA; Buller NP; Lipkin DP
Am J Cardiol; 1988 Sep; 62(8):49E-52E. PubMed ID: 3414537
[TBL] [Abstract][Full Text] [Related]
12. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
14. [Peripheral adaptation in chronic heart failure: therapeutic implications].
Drexler H
Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
[TBL] [Abstract][Full Text] [Related]
15. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
16. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.
Mancini DM; Davis L; Wexler JP; Chadwick B; LeJemtel TH
J Am Coll Cardiol; 1987 Oct; 10(4):845-50. PubMed ID: 3309004
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
[TBL] [Abstract][Full Text] [Related]
18. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
Drexler H; Depenbusch JW; Truog AG; Zelis R; Flaim SF
J Pharmacol Exp Ther; 1987 Apr; 241(1):13-9. PubMed ID: 3553536
[TBL] [Abstract][Full Text] [Related]
19. Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure.
Wilson JR; Ferraro N; Wiener DH
Circulation; 1985 Jul; 72(1):72-81. PubMed ID: 4006138
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
Giudicelli JF; Richer C; Richard C; Thuillez C
Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
